Dipentylone
Identifiers | |
---|---|
IUPAC name
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C14H19NO3 |
Molar mass | 249.310 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Dipentylone (also known as Dimethylpentylone) is a substituted cathinone derivative with stimulant effects,[1] which has been sold as a designer drug,[2][3] first detected in Sweden in 2014.[4]
See also
References
- ↑ Gatch MB, Shetty RA, Sumien N, Forster MJ (July 2021). "Behavioral effects of four novel synthetic cathinone analogs in rodents". Addiction Biology. 26 (4): e12987. doi:10.1111/adb.12987. PMID 33155384.
- ↑ Celma A, Sancho JV, Salgueiro-González N, Castiglioni S, Zuccato E, Hernández F, Bijlsma L (September 2019). "Simultaneous determination of new psychoactive substances and illicit drugs in sewage: Potential of micro-liquid chromatography tandem mass spectrometry in wastewater-based epidemiology". Journal of Chromatography A. 1602: 300–309. doi:10.1016/j.chroma.2019.05.051. PMID 31171357.
- ↑ "Police and drug agency issue strong warning after new drug detected in Dunedin". New Zealand Herald. 8 December 2021.
- ↑ "Europol 2014 Annual Report on the implementation of Council Decision" (PDF). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) – Europol. 2005/387/JHA.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.